Products/Lung Cancer Cell Models

Bastion Lung Cell Model

Bastion Lung Cell Model


 

Product Family: Bastion Lung Cell Model
Disease Area: Cancer
Tissue Type: Lung
Clinical Diagnosis: Squamous cell carcinoma


Disease Area: Cancer
Tissue Type: Lung
Clinical Diagnosis: Squamous cell carcinoma
Age: 70-75
Sex: Female
Ethnicity: Caucasian
TNM Stage: T1aNXM0
Grade: IA
Treatment History: No prior treatment
Co-indications: Hyperlipidemia, Hypertension, Chronic obstructive pulmonary disease, Hyperthyroidism, Gastroesophageal reflux disease, Arthritis, Hysterectomy, Colon resection.
Medications: Advair, Calcium carbonate and vitamin D, Nexium, Tiotropium bromide, Cozaar, Synthroid, Boniva, Lasix, Lipitor
Country of Collection: United States
Year of Origin: 2016


MORPHOLOGY (2D)

 

MUTATIONS

Gene

Alteration

Frequency (%)

Exon

Result

None Reported

 

 

 

 

 

BASTION DRUG RESPONSE

The Bastion Cell Model demonstrates sensitivity to Cisplatin and Etoposide, while showing resistance to Larotrectinib.

 

BASTION GROWTH CHARACTERISTICS

The historical growth curve of Bastion demonstrates consistent and rapid growth. Bastion cells grow continuously for 15+ passages.


 

 

CELL LINE PROTOCOL

See Passaging Protocol: Lung Cohort for detailed Protocol

STORAGE AND SAFETY

Storage and Stability: Store frozen in liquid nitrogen.

Quality Control: All lots are tested for consistent growth capabilities. See Certificate of Analysis for further details.

Connect With Us

Speak To
A Scientist

Contact Now
Regular price
$985.00
Sale price
$985.00
Regular price
Sold out
Unit price
per 

SIZE
1 Million Cells per Cryovial

AVAILABILITY
In stock

PRODUCT CODE
CB-0302